← board
VRXAW
$0.10-28%today-33% from 52w high
Revenue
pre-revenue
Liquidity
—
Runway
—
Shares 1y
—
Price & events
-32.8% over 6M
CatalystRating changeDilutionFinancingdashed = today
-27.5%
1D
-16.7%
1W
—
1M
—
3M
—
6M
—
1Y
—
2Y
—
5Y
-32.8%
All
Overview
- Volume
- 120
- 52 Week Range
- $0.10 – $0.15
- RVOL
- 0.01x
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 0
- No catalyst news yet.
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- none
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.